Decoy Therapeutics is trading at $1.08, down 12.31%, with no company-specific announcement identified to explain the October 30 decline.
- Decoy Therapeutics’ listed press releases were from earlier dates.
- Broader markets were sharply lower: the Nasdaq fell 2.1% and the S&P 500 fell 1.3% in an October 30 report. This provides risk-off context but does not establish a direct cause for the stock’s larger decline.
- No reliable volume figure was available in the provided price context or cited news results.